Childhood psoriasis treatment: Evidence published over the last 5 years

Reviews on Recent Clinical Trials

Volumn 6, Issue 1, 2011, Pages 36-43

  Lara Corrales, I ^a   Xi, N ^a   Pope, E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Children; Psoriasis; Treatment

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; CLOBETASOL PROPIONATE; COAL TAR; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; ETANERCEPT; ETRETIN; INFLIXIMAB; ISOTRETINOIN; METHOTREXATE; METHOXSALEN; PLACEBO; PREDNISOLONE; TAZAROTENE;

ACNE; ADRENAL SUPPRESSION; APPLICATION SITE BURNING; ARTHRALGIA; ARTICLE; ATROPHY; BIOLOGICAL THERAPY; BLEPHARITIS; BLEPHAROCONJUCTIVITIS; BONE MARROW TOXICITY; CALCIFICATION; CHEILITIS; CONJUNCTIVITIS; DIARRHEA; ECCHYMOSIS; EPIPHYSIS DISEASE; EPISTAXIS; EVENING DOSAGE; HEADACHE; HUMAN; HYPEROSTOSIS; HYPERTENSION; KIDNEY DYSFUNCTION; LIVER FIBROSIS; LIVER TOXICITY; LOW DRUG DOSE; NAUSEA; NEPHROTOXICITY; PEDIATRICS; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; PUVA; SIDE EFFECT; SKIN IRRITATION; STOMATITIS; STRIA; TELANGIECTASIA; TERATOGENICITY; TREATMENT RESPONSE; TREMOR; ULTRAVIOLET B RADIATION; VOMITING;

ADMINISTRATION, TOPICAL; ANTIMETABOLITES; CHILD; DIHYDROXYCHOLECALCIFEROLS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PERIODICALS AS TOPIC; PSORIASIS; RETINOIDS; ULTRAVIOLET THERAPY;

EID: 78650950839     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488711793980174     Document Type: Article

References (39)

1. Al-Shobaili H, Al-Khenaizan S. Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol 2007; 24 (5): 563-4.
2. Borska L, Fiala Z, Krejsek J, et al. Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen. Pediatr Dermatol 2007; 24 (6): 607-12.
3. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003; 49 (2): 171-82; quiz 183-6.
4. Burden AD. Identifying a gene for psoriasis on chromosome 6 (Psors1). Br J Dermatol 2000; 143 (2): 238-41.
5. Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol 2009; 34 (3): 295-8.
6. Cordoro KM. Management of childhood psoriasis. Adv Dermatol 2008; 24: 125-69.
7. Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol 1985; 121 (1): 63-7.
8. Dadlani C, Orlow SJ. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol 2005; 52 (2): 316-40.
9. Darley CR, Cunliffe WJ, Green CM, Hutchinson PE, Klaber MR, Downes N. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol 1996; 135 (3): 390-3.
10. Diluvio L, Campione E, Paterno EJ, Mordenti C, El Hachem M, Chimenti S. Childhood nail psoriasis: a useful treatment with tazarotene 0.05%. Pediatr Dermatol 2007; 24 (3): 332-3.
11. Ergin S, Ersoy-Evans S, Sahin S, Ozkaya O. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatol Treat 2008; 19 (6): 341-3.
12. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M. Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 1994; 30 (4): 581-90.
13. Graham LD, Myones BL, Rivas-Chacon RF, Pachman LM. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr 1992; 120 (3): 468-73.
14. Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39 (2): 272-6.
15. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323 (7308): 334-6.
16. Hawrot AC, Metry DW, Theos AJ, Levy ML. Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol 2006; 23 (1): 67-71.
17. Kaur I, Dogra S, De D, Kanwar AJ. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol 2008; 25 (2): 184-8.
18. Kim HS, Kim GM, Kim SY. Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy. Pediatr Dermatol 2006; 23 (3): 306-8.
19. Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008; 59 (3): 448-54, 454 e1.
20. Lacour M, Mehta-Nikhar B, Atherton DJ, Harper JI. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol 1996; 134 (6): 1023-9.
21. nd ed. New York: Marcel Dekker 2003; pp. 179-195.
22. Lebwohl M, Ellis C, Gottlieb A, et al. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 1998; 39 (3): 464-75.
23. Leman J, Burden D. Psoriasis in children: a guide to its diagnosis and management. Paediatr Drugs 2001; 3 (9): 673-80.
24. Leung DY, Travers JB, Giorno R, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96 (5): 2106-12.
25. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18 (3): 188-98.
26. Newman M, Auerbach R, Feiner H, et al. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment. Arch Dermatol 1989; 125 (9): 1218-24.
27. Nyfors A, Lemholt K. Psoriasis in children. A short review and a survey of 245 cases. Br J Dermatol 1975; 92 (4): 437-42.
28. Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med 2008; 358 (3): 241-51.
29. Papoutsaki M, Costanzo A, Mazzotta A, Gramiccia T, Soda R, Chimenti S. Etanercept for the treatment of severe childhood psoriasis. Br J Dermatol 2006; 154 (1): 181-3.
30. nd ed. Philadelphia: Saunders (Elsevier) 2007; pp. 275-300.
31. Pereira GM, Miller JF, Shevach EM. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway. J Immunol 1990; 144 (6): 2109-16.
32. Pereira TM, Vieira AP, Fernandes JC, Sousa-Basto A. Cyclosporin A treatment in severe childhood psoriasis. J Eur Acad Dermatol Venereol 2006; 20 (6): 651-6.
33. Picardi A, Mazzotti E, Gaetano P, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics 2005; 46 (6): 556-64.
34. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 17 (3): 174-8.
35. Reichrath J, Muller SM, Kerber A, Baum HP, Bahmer FA. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J Am Acad Dermatol 1997; 36 (1): 19-28.
36. Rosinska D, Wolska H, Jablonska S, Konca I. Etretinate in severe psoriasis of children. Pediatr Dermatol 1988; 5 (4): 266-72.
37. Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology 2006; 212 (4): 327-37.
38. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol 2000; 1 (3): 159-65.
39. Tzung TY, Wu JC, Hsu NJ, Chen YH, Ger LP. Comparison of tazarotene 0.1% gel plus petrolatum once daily versus calcipotriol 0.005% ointment twice daily in the treatment of plaque psoriasis. Acta Derm Venereol 2005; 85 (3): 236-9.